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Abstract
Background: Computer image analysis techniques have decreased effects of observer biases, and increased the
sensitivity and the throughput of immunohistochemistry (IHC) as a tissue-based procedure for the evaluation of
diseases.
Methods: We adapted a Cyan/Magenta/Yellow/Key (CMYK) model for automated computer image analysis to
quantify IHC stains in hematoxylin counterstained histological sections.
Results: The spectral characteristics of the chromogens AEC, DAB and NovaRed as well as the counterstain
hematoxylin were first determined using CMYK, Red/Green/Blue (RGB), normalized RGB and Hue/Saturation/
Lightness (HSL) color models. The contrast of chromogen intensities on a 0–255 scale (24-bit image file) as well
as compared to the hematoxylin counterstain was greatest using the Yellow channel of a CMYK color model,
suggesting an improved sensitivity for IHC evaluation compared to other color models. An increase in activated
STAT3 levels due to growth factor stimulation, quantified using the Yellow channel image analysis was associated
with an increase detected by Western blotting. Two clinical image data sets were used to compare the Yellow
channel automated method with observer-dependent methods. First, a quantification of DAB-labeled carbonic
anhydrase IX hypoxia marker in 414 sections obtained from 138 biopsies of cervical carcinoma showed strong
association between Yellow channel and positive color selection results. Second, a linear relationship was also
demonstrated between Yellow intensity and visual scoring for NovaRed-labeled epidermal growth factor
receptor in 256 non-small cell lung cancer biopsies.
Conclusion: The Yellow channel image analysis method based on a CMYK color model is independent of
observer biases for threshold and positive color selection, applicable to different chromogens, tolerant of
hematoxylin, sensitive to small changes in IHC intensity and is applicable to simple automation procedures. These
characteristics are advantageous for both basic as well as clinical research in an unbiased, reproducible and high
throughput evaluation of IHC intensity.
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Background
Immunohistochemistry (IHC) for the evaluation of anti-
gen expression as well as higher resolution methodologies
for cytogenetic analysis are standard procedures for the
diagnosis and prognosis of cancer and other diseases [1].
In recent years, cancer treatment response and disease
progression increasingly rely on IHC to monitor changes
in targeted antigens. Abundances of antigens have so far
relied primarily on visual scoring and to a lesser extent
computer-assisted image processing techniques [2]. A
major advantage of computer techniques is the avoidance
of inter-observer variability in interpreting subtle antigen
level changes [3]. In addition, pattern recognition, which
has been applied to image analysis of fluorescence in situ
hybridization [4], may also be applied to IHC image anal-
ysis of compartmentalized antigen distributions, particu-
larly with recent developments in self-learning computer
programs [5]. Most computer-based techniques for IHC
image analysis have so far had limited applicability due to
several drawbacks including a need for specific software
systems, often with considerable need for user input [6-9].
These image analyses have commonly been performed on
the single assessment of 3,3'-diaminobenzidine (DAB)
labeling for a variety of cytoplasmic markers. Conse-
quently, misclassifications were frequently encountered
when two or more chromogens with overlapping absorp-
tion spectra were used simultaneously [6]. Specialized
color deconvolution algorithms can be applied to dis-
criminate multiple spectra [10]. Alternatively, the recent
application of spectral imaging offers an optimal method
to capture and analyze images at multiple wavelengths
[11]. However, digitally captured IHC brightfield images
are usually stored as composites of three 8-bit monochro-
matic red, green and blue channels (RGB), which can be
converted to the Cyan/Magenta/Yellow/Key (CMYK) or
Hue/Saturation/Lightness (HSL) color space. Previously,
components of the RGB [12], their normalization (nR,
nG, nB; nRGB) [6], or HSL [5,8,13] have been applied
towards IHC quantification.
In this study, we adapted a CMYK color model as a simple
method to quantify IHC staining with three commonly
used chromogens including 3-amino-9-ethylcarbazole
(AEC), DAB, and NovaRed with hematoxylin counter-
stain. For simplicity, images of color bars representing
IHC staining were used to characterize the performance of
individual channels in the color models CMYK, RGB,
nRGB and HSL. These results indicated advantages with
the Yellow channel analysis, based on a CMYK color
model. Therefore, the Yellow channel method was further
tested on three applications. First, sensitivities of image
analysis methods were compared in the IHC staining of
phosphorylated signal transduction and transcription fac-
tor-3 (p-STAT3) in tumor xenografts. Following, the per-
formance of a high throughput automated Yellow
channel method was compared to observer-dependent
methods, including positive color selection for a hypoxia
marker carbonic anhydrase-IX (CA-IX)-labeled DAB and
visual scoring for epidermal growth factor receptor
(EGFR)-labeled NovaRed in the second and third applica-
tions, respectively.
Methods
Image acquisition and processing
Slides were scanned with a ScanScope CS (Aperio Tech-
nologies, Vista, CA) using brightfield imaging at 20× mag-
nification. Specimen areas were selected and individual
images were saved in a 24-bit RGB TIFF file format with a
resolution of 1 µm/pixel using the ImageScope software
(Aperio Technologies). The automated analysis of the
TIFF image files was performed using the programming
language IDL 6.3 (ITT Visual Information Solutions, Boul-
der, Colorado) [14,15] for IHC quantification using RGB
[12], normalized RGB [6], HSL [8,13], and CMYK as
described below.
CMYK image analysis method
We adapted a CMYK model with maximum grey compo-
nent replacement, a criterion in which the lowest bright-
ness level is subtracted from all channels. This criterion
effectively discriminates color differences by subtracting
out the grey level, a level of equal intensity among the
three channels (C, M, Y). Consequently, this subtraction
sets one of the color channels to zero in each image. The
selection of this display criterion for an image using a
popular software Adobe® Photoshop®7.0, involves the fol-
lowing sequence of menu selections: Edit, Color settings,
Custom CMYK and Black generation set at Maximum. In
this study, CMYK values were derived from the
CMYK_Convert library procedure in IDL 6.3 using the
equations:
(* indicates multiplication)
K (black) = 255 - maximum(R, G, B)
C = 255* [1 - R/(255 - K)] (if K = 255 then C = 0)
M = 255* [1 - G/(255 - K)] (if K = 255 then M = 0)
Y = 255* [1 - B/(255 - K)] (if K = 255 then Y = 0)
Mean intensity measurements in regions of interest were
computed without the use of positive color intensity
thresholds. However, proportions of labeled area in tissue
were determined with a positive range intensity of 21+
and 93+ for the Yellow and nRed channels, respectively.Diagnostic Pathology 2007, 2:8 http://www.diagnosticpathology.org/content/2/1/8
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Xenograft models
Spectral characteristics of AEC, DAB and NovaRed were
displayed with the different color models using color bars
that were generated from a range of representative IHC
staining derived from the xenograft studies described
below, as well as additional IHC archived slides that
showed a greater range of staining intensity.
Changes in STAT3 phosphorylation (p-STAT3) levels were
associated with different conditions, including growth
factor stimulation and sampling techniques as previously
described [16]. Formalin-fixed paraffin embedded speci-
mens were obtained to compare IHC staining using differ-
ent chromogens AEC, DAB or NovaRed, and hematoxylin
counterstain. Briefly, a tumor xenograft was excised and
divided into two equal parts. One part was further divided
and subjected to immediate formalin fixation, or protein
extraction for Western blot analysis [17]. The second part
was incubated with 50 ng/ml epidermal growth factor
(EGF, Sigma-Aldrich, Oakville, ON) in PBS for 20 minutes
prior to specimen analysis. The antibody S727p-STAT3 (BD
Biosciences, Mississauga, ON) was used for Western blot-
ting at a dilution of 1:100, and anti-GAPDH used at a dilu-
tion of 1:5000 (Ambion, Foster City, CA). Protein bands
were detected with ECL plus fluorescence, imaged with a
Typhoon system and their intensities were quantified
(mean intensity × band area) and normalized with
GAPDH using ImageQuant5.2 software (GE Healthcare,
Little Chalfont, Buckinghamshire, UK).
Second, p-STAT3 levels were also quantified in formalin-
fixed paraffin embedded sections of fine-needle samples
obtained from a tumor xenograft. These samples were
subjected to either immediate or delayed fixation after 5,
20 or 60 minutes, which caused an increase in p-STAT3.
Clinical test sets for comparison with CMYK model
Image analysis was performed on two clinical image data
sets collected for other histopathological studies. The first
study comprised of a total of 414 sections obtained from
three adjacent sections of 138 frozen uterine cervical car-
cinoma biopsies. Carbonic anhydrase-IX-labeled DAB
was previously evaluated with a positive color selection
method [18]. In brief, a visual selection of a range of pos-
itive brown color pixels was performed using Adobe®Pho-
toshop®  7.0 and batched analyzed using the IDL 6.3
programming language. Image analysis was performed in
areas designated by tumor masks.
The second study comprised of a total of 282 formalin-
fixed and paraffin embedded NSCLC biopsies arranged in
8 tissue microarrays which were IHC-stained for EGFR-
labeled NovaRed [19]. Three cores of 0.6 mm diameter
represented each case with evaluation completed on cases
represented by at least 2 cores (n = 256). Two evaluators
visually scored with a scale 0–3 (0 for absence of mem-
brane staining in cancer cells) and their scores were
strongly associated (r = 0.97). Thus, the mean of core
scores was used as the final score for individual cases.
Image analysis was performed in areas designated by
whole tissue core masks since anti-EGFR demonstrated
high specificity for cancer cells.
Immunohistochemistry
Specimens were processed with routine protocols using
anti-S727p-STAT3 (BD Biosciences), anti-CA-IX (a gener-
ous gift of Dr. Adrian Harris, University of Oxford, UK)
[15] and anti-EGFR (clone 31G7, Zymed Technologies,
Invitrogen, Burlington, ON). The Idetect Ultra HRP Detec-
tion System (ID Labs Inc, London, Ontario) was used to
visualize either DAB (Dako Corp, Carpinteria, CA),
NovaRED or AEC (Vector Laboratories). Counterstaining
was performed with Gill modified hematoxylin (Har-
leco®).
Results
IHC spectral characteristics
Four color models, CMYK, RGB, nRGB and HSL, were
applied to examine the spectral characteristics of AEC,
DAB, NovaRed and hematoxylin counterstain (Figure 1).
Chromogen staining in hematoxylin counterstained spec-
imen ranged from absent (color bars 1–3, Figure 1) to
present (color bars 4 to 7, Figure 1) for the respective chro-
mogens in the nuclear compartment sampled. Increasing
chromogen intensity was similar to intensities obtained in
the absence of hematoxylin counterstain [See additional
file 1]. However, in the presence of hematoxylin counter-
stain (Figure 1) the intensity levels of most channels over-
lapped between hematoxylin and chromogen colors
except for those characterized by the Yellow channel, nor-
malized Red channel (nR) or normalized Blue channel
(nB). Interestingly, highest chromogen intensity levels
saturated on the Yellow, nR or nB scale in either the pres-
ence or absence of hematoxylin (Figure 1 and Additional
file 1). This observation suggests that it is important to
remain below chromogen saturation levels for a direct
correlation with intensity levels.
Unique features of the presented Yellow channel included
an automatic setting at zero for the hematoxylin counter-
stain as well as a greater utilization of the 0–255 intensity
scale compared to nR or nB. These characteristics demon-
strated that the Yellow channel achieved a high contrast
between different chromogen intensities as well as
between the tested chromogens and the hematoxylin
counterstain. The performance of the CMYK Yellow chan-
nel method was further tested in three applications which
used other automated and observer-dependent methods.Diagnostic Pathology 2007, 2:8 http://www.diagnosticpathology.org/content/2/1/8
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IHC spectral characteristics Figure 1
IHC spectral characteristics. The color bars designated 1–7 display representative IHC staining, from least to most, using 
AEC, DAB, or NovaRed with hematoxylin counterstained nuclei. Graphs on sequential rows depict the IHC colors defined by 
the individual channel intensity of CMYK, RGB, nRGB and HSL color model.
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STAT3 activation
Levels of activated STAT3 induced by EGF were quantified
in IHC-stained xenografts using Yellow channel image
analysis (Figure 2A). Despite considerable heterogeneity
in activated STAT3 IHC staining as displayed from the
images [see additional file 2], an increase in staining is
noticeable after EGF stimulation within the viable tumor
area which is in agreement with Western blotting (Figure
2B). A comparison of different color channel analyses
showed that measurements obtained from the Yellow
channel were consistently more sensitive to increases in
staining intensity, particularly with the AEC substrate
(Table 1).
Furthermore, image analysis was applied to a series of
small fine-needle samples which displayed differences in
STAT3 activation (Figure 3A). Mean Yellow intensity
measurements showed an increase in staining intensities
with a maximum at 20 minutes (Figure 3B). This result
was in agreement with a previously observed biological
trend [16]. Measurements of IHC staining showed greater
magnitudes of change using Yellow compared to the nor-
malized Red channel analysis. Additionally, the Yellow
channel was relatively unaffected by the hematoxylin
which resulted in a slightly higher Key channel intensity at
the initial compared to the last time point.
Positive color selection analysis compared to CMYK
The more arbitrary method using positive color selection
of CA-IX levels [18] was compared to results obtained
using Yellow channel analysis (Figure 4A). Since CA-IX
staining was characterized by a heterogeneous pattern
rather than a ubiquitously distribution in all cells, the
fraction of labeled cells was of primary interest. Positively
labeled area fractions were strongly correlated between
the two methods (Figure 4B). Although the mean Yellow
intensity measurements were also strongly correlated with
area fractions using positive color selection analysis (Fig-
ure 4C), the slight decrease in the correlation of these
parameters at the higher end suggests higher variability in
CA-IX levels in tumors with larger fractions of CA-IX
STAT3 activation in EGF-stimulated tumor tissue Figure 2
STAT3 activation in EGF-stimulated tumor tissue. 
(A) Yellow channel image analysis was performed on consec-
utive sections detecting p-STAT3 labeled with each of the 
three chromogens and counterstained with hematoxylin. (B) 
An increase in p-STAT3 was detected by Western blotting.
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Table 1: Activation of STAT3
Channel EGF Stimulation (%)
AEC DAB NovaRed
Yellow 180 130 120
nRed 106 103 102
Key 110 120 110
Mean IHC-p-STAT3 intensity was quantified using different color 
channels. Effects of EGF stimulation were expressed relative to 
control.Diagnostic Pathology 2007, 2:8 http://www.diagnosticpathology.org/content/2/1/8
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STAT3 activation after delayed tissue fixation Figure 3
STAT3 activation after delayed tissue fixation. (A) Phosphorylated STAT3-labeled AEC and hematoxylin counterstained 
representative images are shown in full color and Yellow intensity as shown in grayscale. (B) The mean Yellow intensity within 
the entire area of the four specimens shows a staining increase with a maximum at 20 minutes. This increase was smaller in 
magnitude and undetectable in results obtained from the normalized Red and the Key channel, respectively.
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labeled areas. Strong associations were obtained between
results from positive color selection and the Yellow or the
normalized Red channel (Table 2). Measurements of per-
cent of positive area showed strong associations among all
methods as was expected, since a fixed positive threshold/
range intensity was used in each case. However, measure-
ments from the positive color selection method have a
higher association with intensity measurements from the
Yellow rather than the normalized Red channel. This
result suggested that the Yellow intensity provides an
observer bias-free measurement with relatively high accu-
racy.
Pathological visual scoring compared to CMYK
The mean IHC intensity of each biopsy based on a visual
scoring performed by two pathologists (Figure 5A)
showed a direct relationship (r = 0.89) with mean Yellow
intensity measurements (Figure 5B). Interestingly, a
higher variability characterized the lower and the upper
ends of the scoring range (e.g. 0–1 and 2.5–3) compared
to the middle of the scoring categories. This result suggests
some cases at either end of the scale were misclassified
and might be due to inconsistencies in the visual scores,
or inclusion of non-specific staining with an automatic
analysis based on whole tissue core. However, the major-
ity of the cases from the different scoring categories were
grouped within the non-overlapping top and bottom 25th
percentile of the Yellow intensity values.
Discussion
Levels of IHC stains are increasingly used to monitor bio-
logical disease markers during cancer treatment and dis-
ease progression. This image analysis study tested the use
of the Yellow channel of a CMYK color model for IHC
quantification. Although the programming language IDL
6.3 was used to automate the analysis process here, the
availability of the CMYK model with maximum grey com-
ponent replacement function in popular image processing
software packages makes this method readily accessible.
Spectral characterization of the chromogens AEC, DAB
and NovaRed in the absence of the hematoxylin counter-
stain showed a relationship with at least one channel of
all color models, consistent with the RGB and HSL results
in previous reports [6,8,12]. However, in the presence of
the hematoxylin counterstain the Yellow channel analysis
method applied here achieved the best contrast on a 0–
255 scale, between chromogen and hematoxylin as well as
for different chromogen intensities. These characteristics
of the Yellow channel resulted in a higher sensitivity
towards detecting subtle IHC intensity changes relevant to
markers associated with treatment response, prognosis
and pathobiology of cancers in the examples presented in
this paper.
The least amount of observer-dependent input was
applied to the image analysis process. Analyses were per-
formed in regions of interest with the omission of obvious
dark artifacts which may occur due to mixing with endog-
enous pigments, debris, tissue drying and other method-
dependent variables as recognized in such tissue process-
ing techniques [2,20]. Although a comprise on the inten-
sity scale occurs when the IHC stain is near black as
presented in the results, the saturated chromogen intensi-
ties remained within the higher levels of the intensity scale
and therefore was likely negligible. Alternatively, inde-
pendent of intensity levels, measurements were also eval-
uated based on proportions of labeled area, but it is
dependent on observer selection of positive intensity
ranges.
Antigen expression in tissue sections can be expressed as
either the mean staining intensity or the stained area frac-
tion. The mean staining intensity measurements
described in this paper show changes in relative antigen
expression when these were ubiquitously expressed, or
equally distributed in compartment(s) of interest. These
antigen characteristics suggest that other frequently IHC-
labeled antigens such as proliferation and apoptosis
markers can also be quantified using image analysis meth-
ods such as Yellow channel in addition to conventional
estimates of their presence or absence. These markers have
been informative for the further sub-classification of can-
cer stages identified using standard histology [21,22].
However, in scenarios where differences in cellular distri-
butions are important for disease profiling [23] recent
developments in pattern recognition programs are possi-
ble solutions [5].
Table 2: A comparison of image analysis methods
Yellow channel nRed channel
Intensity (mean) % Positive area Intensity (mean) % Positive area
Positive color selection (% positive area) 0.96 0.98 0.84 0.98
Values (correlation coefficient, r) indicate strength of a linear relationship between results from positive color selection and Yellow or normalized 
Red analysis method, where a maximum positive is r = 1.Diagnostic Pathology 2007, 2:8 http://www.diagnosticpathology.org/content/2/1/8
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Positive color selection compared to CMYK analysis Figure 4
Positive color selection compared to CMYK analysis. (A) A representative field of 411 sections of cervical carcinoma 
shows CA-IX-DAB labeling with hematoxylin counterstain in full color and in Yellow intensity as shown in grayscale. (B) Per-
centages of IHC-labeled area as well as (C) mean intensity were analyzed using the Yellow channel and either results display a 
strong association with results obtained from positive color selection method.
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The analysis of different IHC applications here demon-
strated that the Yellow-CMYK channel method provides
consistent results as well as higher performance for IHC
quantification compared to other automated and manual
techniques. The Yellow channel has several advantages,
including its applicability to different chromogens, toler-
ance of hematoxylin, greater utilization of the intensity
scale and readiness for automation. In particular, the
mean Yellow intensity measurements are independent of
arbitrary threshold selection. These advantages are impor-
tant to IHC-based analysis in basic as well as clinical
research [24] where the biological changes as well as
methodological variances need to be quantified in an
unbiased, reproducible and high throughput manner.
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Visual scoring compared to CMYK analysis Figure 5
Visual scoring compared to CMYK analysis. (A) Repre-
sentative images of 256 NSCLC biopsies show plasma mem-
brane specific EGFR-NovaRed labeling with visual scores 
ranging from 0–3. (B) A box and whiskers graph (median, 
25% to 75% box range, min and max whiskers) representa-
tion of mean Yellow intensity of specimens shows a direct 
relationship with the categorical visual scores.
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